Trading Window

MANUFACTURER OF BULK DRUGS & IMPORTERS OF SOLVENTS & CHEMICALS H.O: 203/4 SAHAKAR BHAVAN, 340/48 N.N STREET, MUMBAI-400009 : (022) 23455543 Email: corporate@aareydrugs.com REGD OFF. & FACTORY: E-34 MIDC, TARAPUR, BOISAR, DIST.-THANE (02525) 271049 Email: info@aareydrugs.com CIN:L99999MH1990PLC056538 Date: 26th June, 2026 BSE Limited National Stock Exchange of India Limited The Manager, Exchange Plaza Corporate Service Department Bandra Kurla Complex, P.J. Towers, Dalal Street, Bandra (E), Mumbai- 400 001 Mumbai – 400051 Scrip Code: 524412 NSE Symbol: AAREYDRUGS Subject: Intimation of Closure of Trading Window Dear Sir/Ma’am, Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and with reference to Circulars issued by BSE vide Circular No. LIST/COMP/01/2019-20 and NSE vide Circular No. NSE/CMU2019/11 dated April 02, 2019, we wish to inform you that the trading window for dealing in the securities/shares of Aarey Drugs and Pharmaceuticals Limited will remain closed for Insiders, Designated Persons and their immediate relatives with effect from Wednesday, July 01, 2026, till the completion of 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter ended June 30, 2026. The Company has intimated its Designated Persons regarding the closure of the trading window. Accordingly, Insiders, Designated Persons and their immediate relatives of the Company are advised not to trade (buy or sell or pledge, etc.) in the securities/shares of the Company during the aforesaid period of closure of the trading window. Board Meeting date for consideration and approval of Unaudited Financial Results of the Company for the quarter ended June 30, 2026 shall be intimated in due course. Kindly take the above information on your records. Thanking you, Yours faithfully, For Aarey Drugs and Pharmaceuticals Limited Nimit Ghatalia Director DIN: 07069841